Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB
Abstract There is strong interest in developing predictive models to better understand individual heterogeneity and disease progression in Alzheimer's disease (AD). We have built upon previous longitudinal AD progression models, using a nonlinear, mixed‐effect modeling approach to predict Clinical D...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wiley
2023-07-01
|
| Seria: | CPT: Pharmacometrics & Systems Pharmacology |
| Dostęp online: | https://doi.org/10.1002/psp4.12974 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|